BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 23512657)

  • 1. Structural basis of protein complex formation and reconfiguration by polyglutamine disease protein Ataxin-1 and Capicua.
    Kim E; Lu HC; Zoghbi HY; Song JJ
    Genes Dev; 2013 Mar; 27(6):590-5. PubMed ID: 23512657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis of the phosphorylation dependent complex formation of neurodegenerative disease protein Ataxin-1 and RBM17.
    Kim E; Lee Y; Choi S; Song JJ
    Biochem Biophys Res Commun; 2014 Jul; 449(4):399-404. PubMed ID: 24858692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical shift assignment of the ataxin-1 AXH domain in complex with a CIC ligand peptide.
    de Chiara C; Kelly G; Menon RP; McCormick J; Pastore A
    Biomol NMR Assign; 2014 Oct; 8(2):325-7. PubMed ID: 23853075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A key lysine residue in the AXH domain of ataxin-1 is essential for its ubiquitylation.
    Kang AR; Park SH; Lee S; Choi DY; Kim KP; Song HK; Hong S; Kang S
    Biochim Biophys Acta; 2015 May; 1854(5):356-64. PubMed ID: 25641559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opposing effects of polyglutamine expansion on native protein complexes contribute to SCA1.
    Lim J; Crespo-Barreto J; Jafar-Nejad P; Bowman AB; Richman R; Hill DE; Orr HT; Zoghbi HY
    Nature; 2008 Apr; 452(7188):713-8. PubMed ID: 18337722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein-protein interactions as a strategy towards protein-specific drug design: the example of ataxin-1.
    de Chiara C; Menon RP; Kelly G; Pastore A
    PLoS One; 2013; 8(10):e76456. PubMed ID: 24155902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The structure of the AXH domain of spinocerebellar ataxin-1.
    Chen YW; Allen MD; Veprintsev DB; Löwe J; Bycroft M
    J Biol Chem; 2004 Jan; 279(5):3758-65. PubMed ID: 14583607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The AXH domain adopts alternative folds the solution structure of HBP1 AXH.
    de Chiara C; Menon RP; Adinolfi S; de Boer J; Ktistaki E; Kelly G; Calder L; Kioussis D; Pastore A
    Structure; 2005 May; 13(5):743-53. PubMed ID: 15893665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial loss of ataxin-1 function contributes to transcriptional dysregulation in spinocerebellar ataxia type 1 pathogenesis.
    Crespo-Barreto J; Fryer JD; Shaw CA; Orr HT; Zoghbi HY
    PLoS Genet; 2010 Jul; 6(7):e1001021. PubMed ID: 20628574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial loss of Tip60 slows mid-stage neurodegeneration in a spinocerebellar ataxia type 1 (SCA1) mouse model.
    Gehrking KM; Andresen JM; Duvick L; Lough J; Zoghbi HY; Orr HT
    Hum Mol Genet; 2011 Jun; 20(11):2204-12. PubMed ID: 21427130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duplication of Atxn1l suppresses SCA1 neuropathology by decreasing incorporation of polyglutamine-expanded ataxin-1 into native complexes.
    Bowman AB; Lam YC; Jafar-Nejad P; Chen HK; Richman R; Samaco RC; Fryer JD; Kahle JJ; Orr HT; Zoghbi HY
    Nat Genet; 2007 Mar; 39(3):373-9. PubMed ID: 17322884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the zebrafish atxn1/axh gene family.
    Carlson KM; Melcher L; Lai S; Zoghbi HY; Clark HB; Orr HT
    J Neurogenet; 2009; 23(3):313-23. PubMed ID: 19085187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exercise and genetic rescue of SCA1 via the transcriptional repressor Capicua.
    Fryer JD; Yu P; Kang H; Mandel-Brehm C; Carter AN; Crespo-Barreto J; Gao Y; Flora A; Shaw C; Orr HT; Zoghbi HY
    Science; 2011 Nov; 334(6056):690-3. PubMed ID: 22053053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-assembly and conformational heterogeneity of the AXH domain of ataxin-1: an unusual example of a chameleon fold.
    de Chiara C; Rees M; Menon RP; Pauwels K; Lawrence C; Konarev PV; Svergun DI; Martin SR; Chen YW; Pastore A
    Biophys J; 2013 Mar; 104(6):1304-13. PubMed ID: 23528090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyglutamine is not all: the functional role of the AXH domain in the ataxin-1 protein.
    de Chiara C; Menon RP; Dal Piaz F; Calder L; Pastore A
    J Mol Biol; 2005 Dec; 354(4):883-93. PubMed ID: 16277991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of the dopamine receptor D2 in mice lacking ataxin 1.
    Goold R; Hubank M; Hunt A; Holton J; Menon RP; Revesz T; Pandolfo M; Matilla-Dueñas A
    Hum Mol Genet; 2007 Sep; 16(17):2122-34. PubMed ID: 17599952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond the glutamine expansion: influence of posttranslational modifications of ataxin-1 in the pathogenesis of spinocerebellar ataxia type 1.
    Ju H; Kokubu H; Lim J
    Mol Neurobiol; 2014 Dec; 50(3):866-874. PubMed ID: 24752589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ATAXIN-1 interacts with the repressor Capicua in its native complex to cause SCA1 neuropathology.
    Lam YC; Bowman AB; Jafar-Nejad P; Lim J; Richman R; Fryer JD; Hyun ED; Duvick LA; Orr HT; Botas J; Zoghbi HY
    Cell; 2006 Dec; 127(7):1335-47. PubMed ID: 17190598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional rescue of spinocerebellar ataxia type 1 phenotypes by 14-3-3epsilon haploinsufficiency in mice underscores complex pathogenicity in neurodegeneration.
    Jafar-Nejad P; Ward CS; Richman R; Orr HT; Zoghbi HY
    Proc Natl Acad Sci U S A; 2011 Feb; 108(5):2142-7. PubMed ID: 21245341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of the ATXN1-CIC complex reveals the role of additional nuclear ATXN1 interactors in spinocerebellar ataxia type 1.
    Coffin SL; Durham MA; Nitschke L; Xhako E; Brown AM; Revelli JP; Villavicencio Gonzalez E; Lin T; Handler HP; Dai Y; Trostle AJ; Wan YW; Liu Z; Sillitoe RV; Orr HT; Zoghbi HY
    Neuron; 2023 Feb; 111(4):481-492.e8. PubMed ID: 36577402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.